EFFICACY OF OMALIZUMAB IN THE TREATMENT OF SEVERE ALLERGIC ASTHMA

  • Laima Kondratavičienė
DOI: https://doi.org/10.37499/PIA.152
Keywords: severe allergic asthma, omalizumab, IgE, eozinophils

Abstract

Omalizumab is amonoclonal antibody against immunoglobulin E (IgE), the first biologic developed for the treatment of severe allergic asthma. Clinical trials demonstrated a reduction of severe asthma exacerbations and improve the quality of life.

Author Biography

Laima Kondratavičienė

Department of Pulmonology, Medical Academy, Lithuanian University of Health Sciences

How to Cite
1.
Kondratavičienė L. EFFICACY OF OMALIZUMAB IN THE TREATMENT OF SEVERE ALLERGIC ASTHMA [Internet]. PIA 2020 Sep.;3(1):88-92.[cited 2024 May 19 ] Available from: http://pia.pulmoalerg.lt/index.php/PIA/article/view/152
Issue
Vol 3 No 1 (2019): Pulmonology and Allergology
Section
Pharmacotherapy